Skip to main content
Log in

A novel clot lysis assay for recombinant plasminogen activator

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Recombinant plasminogen activator (r-PA, reteplase) is an engineered variant of alteplase. When expressed in E. coli, it appears as inclusion bodies that require refolding to recover its biological activity. An important step following refolding is to determine the activity of refolded protein. Current methods for enzymatic activity of thrombolytic drugs are costly and complex. Here a straightforward and low-cost clot lysis assay was developed. It quantitatively measures the activity of the commercial reteplase and is also capable of screening refolding conditions. As evidence for adequate accuracy and sensitivity of the current assay, r-PA activity measurements are shown to be comparable to those obtained from chromogenic substrate assay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Alkjaersig N, Fletcher AP, Sherry S (1959) The mechanism of clot dissolution by plasmin. J Clin Invest 38:1086–1095

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Apte-Deshpnade A, Mandal G, Soorapaneni S, Prasad B, Kumar J, Padmanabhan S (2009) High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris. Biotechnol Lett 31:811–817

    Article  CAS  PubMed  Google Scholar 

  • Astrup T, Mullertz S (1952) The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 40:346–351

    Article  CAS  PubMed  Google Scholar 

  • Beebe DP, Aronson DL (1987) An automated fibrinolytic assay performed in microtiter plates. Thromb Res 47:123–128

    Article  CAS  PubMed  Google Scholar 

  • Cylwik D, Mogielnicki A, Kramkowski K, Stokowski J, Buczko W (2004) Antithrombotic effect of l-arginine in hypertensive rats. J Physiol Pharmacol 55:563–574

    CAS  PubMed  Google Scholar 

  • De Bernardez Clark E, Schwarz E, Rudolph R (1999) Inhibition of aggregation side reactions during in vitro protein folding. Method Enzymol 309:217–236

    Article  Google Scholar 

  • Fazeli A, Shojaosadati SA, Fazeli MR, Ilka H (2011) Effect of parallel feeding of oxidizing agent and protein on fed-batch refolding process of recombinant IFNβ-1b. Process Biochem 46:796–800

    Article  CAS  Google Scholar 

  • Jones AJS, Meunier AM (1990) A precise and rapid microtiter plate clot lysis assay: methodology, kinetic modelling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost 64:455–463

    CAS  PubMed  Google Scholar 

  • Kessner A, Troll W (1976) Fluorometric microassay of plasminogen activators. Arch Biochem Biophys 176:411–416

    Article  CAS  PubMed  Google Scholar 

  • Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685

    Article  CAS  PubMed  Google Scholar 

  • Lewis ML, Nachtwey DS, Damron KL (1991) A miniaturized fibrinolytic assay for plasminogen activators. Thromb Res 64:223–234

    Article  CAS  PubMed  Google Scholar 

  • Nordt TK, Bode C (2003) Thrombolysis: newer thrombolytic agents and their role in clinical medicine. Heart 89:1358–1362

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Okuda M, Yamamoto Y (2004) Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference. Clin Lab Haematol 26:215–233

    Article  CAS  PubMed  Google Scholar 

  • Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF (2006) Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb J 4:14

    Article  PubMed Central  PubMed  Google Scholar 

  • Rijken DC, Lijnen HR (2009) New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost 7:4–13

    Article  CAS  PubMed  Google Scholar 

  • Saito Y, Ishii Y, Sasaki H, Hayashi M, Fujimura T, Imai Y, Nakamura S, Suzuki S, Notani J, Asada T (1994) Production and characterization of a novel tissue-type plasminogen activator derivative in Escherichia coli. Biotechnol Prog 10:472–479

    Article  CAS  PubMed  Google Scholar 

  • Sherry S, Alkjaersig N, Fletcher AP (1966) Activity of plasmin and streptokinase-activator on substituted arginine and lysine esters. Thromb Diath Haemorrh 16:18–31

    CAS  PubMed  Google Scholar 

  • Sidelmann J, Jespersen J, Gram J (1995) Plasminogen activator activity and plasma-coagulum lysis measured by use of optimized fibrin gel structure preformed in microtiter plates. Clin Chem 41:979–985

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to Zistdaru Danesh Company for their generous gift of r-PA inclusion bodies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sameereh Hashemi-Najafabadi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jamialahmadi, O., Fazeli, A., Hashemi-Najafabadi, S. et al. A novel clot lysis assay for recombinant plasminogen activator. Biotechnol Lett 37, 593–600 (2015). https://doi.org/10.1007/s10529-014-1711-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-014-1711-2

Keywords

Navigation